These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 41997

  • 1. Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
    Magistretti PJ, Schorderet M.
    Life Sci; 1979 Nov 05; 25(19):1675-86. PubMed ID: 41997
    [No Abstract] [Full Text] [Related]

  • 2. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH, Dvorkin B, Horowitz SG, Thal LJ.
    Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965
    [Abstract] [Full Text] [Related]

  • 3. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
    Beart PM, Krstich M, McDonald D, Gundlach AL.
    Neurosci Lett; 1982 Apr 16; 29(2):147-51. PubMed ID: 6123968
    [Abstract] [Full Text] [Related]

  • 4. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
    Redburn DA, Clement-Cormier Y, Lam DM.
    Life Sci; 1980 Jul 07; 27(1):23-31. PubMed ID: 6105607
    [No Abstract] [Full Text] [Related]

  • 5. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro].
    Oelssner W, Peinhardt G, Büge A.
    Pharmazie; 1985 May 07; 40(5):341-2. PubMed ID: 2863832
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ, Iversen LL.
    J Neurochem; 1981 Nov 07; 37(5):1130-43. PubMed ID: 7299392
    [Abstract] [Full Text] [Related]

  • 7. [3H]Spiroperidol (spiperone) binding to a putative dopamine receptor in sheep and steer pituitary and stalk median eminence.
    Cronin MJ, Weiner RI.
    Endocrinology; 1979 Feb 07; 104(2):307-12. PubMed ID: 446362
    [No Abstract] [Full Text] [Related]

  • 8. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 9. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H, Sudo K, Sano M.
    Eur J Pharmacol; 1979 Nov 16; 59(3-4):245-51. PubMed ID: 43256
    [Abstract] [Full Text] [Related]

  • 10. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
    Lerner MH, Rosengarten H, Friedhoff AJ.
    Life Sci; 1981 Dec 07; 29(23):2367-74. PubMed ID: 6172690
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
    Thal LJ, Horowitz SG, Dvorkin B, Makman MH.
    Brain Res; 1980 Jun 16; 192(1):185-94. PubMed ID: 7378779
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA, Mahler HR.
    J Neurochem; 1981 Mar 16; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract] [Full Text] [Related]

  • 13. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL, Largent BL, Snyder SH.
    Life Sci; 1984 Nov 05; 35(19):1981-8. PubMed ID: 6149442
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of 3H-spiroperidol binding by an endogenous material from brain.
    Lahti RA, Gay DD, Barsuhn C.
    Eur J Pharmacol; 1978 Dec 15; 53(1):117-8. PubMed ID: 738355
    [No Abstract] [Full Text] [Related]

  • 15. Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamine.
    Titeler M.
    Biochem Pharmacol; 1981 Nov 15; 30(22):3031-7. PubMed ID: 7337719
    [No Abstract] [Full Text] [Related]

  • 16. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
    Hartley EJ, Spuhler K, Prasad KN, Seeman P.
    Brain Res; 1980 May 26; 190(2):574-7. PubMed ID: 6154511
    [No Abstract] [Full Text] [Related]

  • 17. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D, Tassin JP, Bockaert J.
    Brain Res; 1980 Feb 03; 183(1):235-40. PubMed ID: 7357406
    [No Abstract] [Full Text] [Related]

  • 18. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB, Creese I, Snyder SH.
    J Neurochem; 1980 Mar 03; 34(3):669-76. PubMed ID: 6766497
    [No Abstract] [Full Text] [Related]

  • 19. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
    Leysen JE, Gommeren W.
    J Neurochem; 1981 Jan 03; 36(1):201-19. PubMed ID: 7463046
    [Abstract] [Full Text] [Related]

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov 03; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.